FDA May Tighten Rules On Omniscan, A GE MRI Drug
Read More:
Kidney Damage,
General Electric,
Bayer,
Mallinckrodt,
Magnevist,
Nsf,
Fda,
Omniscan,
Ominiscan,
Ge Healthcare,
Nephrogenic Systemic Fibrosis,
Mri,
Mri Drugs,
Ge,
Business News
The U.S. Food and Drug Administration is weighing further regulation of three drugs used to create high-contrast images on MRI scans, based on a new a...
BusinessWeek / ProPublica | Jeff Gerth | Posted 12.03.2009 | Business